Did you know that more than half of biotech CEOs are stepping into the role for the first time?

At MacDougall, we’ve been advising biotech C-suite leaders for decades and intimately understand the unique challenges these leaders must overcome. In fact, according to Harvard Business Review, “once people reach the C-suite, technical and functional expertise matters less than leadership skills and a strong grasp of business fundamentals.” Unfortunately for many leaders that have moved from the bench to the boardroom, the skills that have historically propelled their career tend to offer diminishing returns as they enter the C-suite.

In our experience, having seasoned professionals to lean on when tackling a first-time leadership role is critical, particularly in an industry where 90 percent of drugs fail to reach the market and missteps can foreclose opportunity. MacDougall has served as a trusted resource for countless leaders in its 20-year history and that’s why we recently launched a workshop for C-suite executives.

Led by Managing Directors Megan Prock McGrath and Sara Michelmore, the course is a half-day interactive workshop featuring one-on-one guidance and counsel for executives looking to weave together data and narrative storytelling to reach and inspire employees, investors, media and other key stakeholders.